James Lomas
Biographic Data
| ID | 6891756 |
|---|---|
| NAME | James Lomas |
| GIVEN NAMES | James |
| FAMILY NAME | Lomas |
| SIGNATURE | LOMAS J |
| AFFILIATIONS | University of York |
| ORCID | 0000-0002-2478-7018 |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 6 |
| AUTHOR COUNT | 8 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 1 |
Sampson and Cookson's commentary: What is it good for
Apples and oranges
The impact of different types of NHS expenditure on health: Marginal cost per Qaly estimates for England for 2016/17
English data from 2003 to 2012 suggests that it costs the NHS £10,000 to generate an additional quality-adjusted life year (QALY). This estimate relates to all NHS expenditure and no attempt was made to explore possible heterogeneity within this total. Different types of expenditure - such as secondary care, primary care and specialized commissioning - may have different productivities and estimates of these may help policymakers decide where add…
Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countries
Economic evaluation of health-related projects requires principles and methods to address the various trade-offs that need to be made between costs and benefits, across sectors and social objectives, and over time. Existing guidelines for economic evaluation in low- and middle-income countries embed implicit assumptions about expected changes in the marginal cost per unit of health produced by the healthcare sector, the consumption value of healt…
Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
INTRODUCTION: Estimating the value of providing effective healthcare interventions in a country requires an assessment of whether the improvement in health outcomes they offer exceeds the improvement in health that would have been possible if the resources required had, instead, been made available for other healthcare activities in that country. This potential alternative use of the same resources represents the health opportunity cost of provid…
Accounting for Timing when Assessing Health-Related Policies
The primary focus of this paper is to offer guidance on the analysis of time streams of effects that a project may have so that they can be discounted appropriately. This requires a framework that identifies the common parameters that need to be assessed, whether conducting cost-effectiveness or benefit-cost analysis. The quantification and conversion of the time streams of different effects into their equivalent health, health care cost or consu…
Estimating health opportunity costs in low-income and middle-income countries: A novel approach and evidence from cross-country data
The economic evaluation of healthcare interventions requires an assessment of whether the improvement in health outcomes they offer exceeds the improvement in health that would have been possible if the additional resources required had, instead, been made available for other healthcare activities. Therefore, some assessment of these health opportunity costs is required if the best use is to be made of the resources available for healthcare. This…
Economic Evaluation of Environmental Interventions: Reflections on Methodological Challenges and Developments
Evaluation of the costs and outcomes associated with environmental policies and interventions is often required to inform public policy and allocate scarce resources. Methods to conduct assessments of cost-effectiveness have been developed in the context of pharmaceuticals, but have more recently been applied in public health, diagnostics, and other more complex interventions. The suitability of existing economic evaluation methodology has been e…
Accounting for Timing when Assessing Health-Related Policies
The primary focus of this paper is to offer guidance on the analysis of time streams of effects that a project may have so that they can be discounted appropriately. This requires a framework that identifies the common parameters that need to be assessed, whether conducting cost-effectiveness or benefit-cost analysis. The quantification and conversion of the time streams of different effects into their equivalent health, health care cost or consu…
Estimating health opportunity costs in low-income and middle-income countries: A novel approach and evidence from cross-country data
The economic evaluation of healthcare interventions requires an assessment of whether the improvement in health outcomes they offer exceeds the improvement in health that would have been possible if the additional resources required had, instead, been made available for other healthcare activities. Therefore, some assessment of these health opportunity costs is required if the best use is to be made of the resources available for healthcare. This…
Economic Evaluation of Environmental Interventions: Reflections on Methodological Challenges and Developments
Evaluation of the costs and outcomes associated with environmental policies and interventions is often required to inform public policy and allocate scarce resources. Methods to conduct assessments of cost-effectiveness have been developed in the context of pharmaceuticals, but have more recently been applied in public health, diagnostics, and other more complex interventions. The suitability of existing economic evaluation methodology has been e…
Accounting for Timing when Assessing Health-Related Policies
The primary focus of this paper is to offer guidance on the analysis of time streams of effects that a project may have so that they can be discounted appropriately. This requires a framework that identifies the common parameters that need to be assessed, whether conducting cost-effectiveness or benefit-cost analysis. The quantification and conversion of the time streams of different effects into their equivalent health, health care cost or consu…
Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
INTRODUCTION: Estimating the value of providing effective healthcare interventions in a country requires an assessment of whether the improvement in health outcomes they offer exceeds the improvement in health that would have been possible if the resources required had, instead, been made available for other healthcare activities in that country. This potential alternative use of the same resources represents the health opportunity cost of provid…
Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countries
Economic evaluation of health-related projects requires principles and methods to address the various trade-offs that need to be made between costs and benefits, across sectors and social objectives, and over time. Existing guidelines for economic evaluation in low- and middle-income countries embed implicit assumptions about expected changes in the marginal cost per unit of health produced by the healthcare sector, the consumption value of healt…
The impact of different types of NHS expenditure on health: Marginal cost per Qaly estimates for England for 2016/17
English data from 2003 to 2012 suggests that it costs the NHS £10,000 to generate an additional quality-adjusted life year (QALY). This estimate relates to all NHS expenditure and no attempt was made to explore possible heterogeneity within this total. Different types of expenditure - such as secondary care, primary care and specialized commissioning - may have different productivities and estimates of these may help policymakers decide where add…
Sampson and Cookson's commentary: What is it good for
Apples and oranges
Economics (6 works) · Business (5 works) · Health Systems, Economic Evaluations, Quality of Life (5 works) · Economic growth (4 works) · Global Health Care Issues (4 works) · Health care (4 works) · Healthcare Policy and Management (4 works) · Medicine (4 works) · Actuarial science (3 works) · Economic evaluation (3 works)